In order to investigate possible reasons for differential patient survival across BRCA1 mRNA low versus high groups in BC and CRC, we evaluated the relative proportion of different races across these groups as it is known that African American patients are more likely to get CRC and are more likely to die from this disease [37]. The gene discussed is BRCA1; the disease is colorectal carcinoma.